Kd. Donovan et al., INTRAVENOUS FLECAINIDE VERSUS AMIODARONE FOR RECENT-ONSET ATRIAL-FIBRILLATION, The American journal of cardiology, 75(10), 1995, pp. 693-697
In a randomized, double-blind, controlled study of 98 patients with at
rial fibrillation (AF) (present for greater than or equal to 30 minute
s, less than or equal to 72 hours, and a ventricular response of great
er than or equal to 100 beats/min), intravenous flecainide (2 mg/kg, m
aximum 150 mg) was compared with intravenous amiodarone (7 mg/kg) and
placebo. Exclusion criteria included significant left ventricular dysf
unction, inotrope dependence, recent antiarrhythmic therapy, hypokalem
ia, and pacemaker dependence. Reversion to stable sinus rhythm within
2 hours of starting medication was considered likely to be due to drug
effect. Twenty of 34 patients (59%) given flecainide, 11 of 32 (34%)
given amiodarone, and 7 of 32 (22%) given placebo reverted to stable s
inus rhythm in less than or equal to 2 hours after starting medication
(chi-square 9.87, p = 0.007). More patients reverted to stable rhythm
with flecainide than with placebo (p = 0.005; odds ratio 5.1, 95% con
fidence interval 1.54 to 17.5). There was no significant difference be
tween amiodarone and placebo or between flecainide and amiodarone. How
ever, after 8 hours there were no significant differences in reversion
between the treatment groups: flecainide (n = 23, 68%), amiodarone (n
= 19, 59%), and placebo (n = 18, 56%). Amiodarone promptly reduced th
e ventricular rate, and this effect was maintained for 8 hours in thos
e whose reversion to stable sinus rhythm was unsuccessful: flecainide
was no more effective than placebo in controlling ventricular rate. Ad
verse effects were not significantly different in the 3 groups. Thus,
intravenous flecainide results in earlier reversion of AF than does in
travenous amiodarone or placebo. Amiodarone, although less effective i
n reverting AF, slows the rapid ventricular response. Drug treatment m
ay be unnecessary for recent-onset, AF, especially if patients are hem
odynamically stable and without significant symptoms: Nearly 60% of pa
tients will return to sinus rhythm within a few hours without any trea
tment.